Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boggild

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|October 24, 1992
Intracerebral haemorrhage after dermal nitrate applicationM Boggild
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
The UK Multiple Sclerosis databaseJ Palace, M Boggild
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2009
Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?R Ellis, M Boggild
The Cochrane Database of Systematic Reviews|October 30, 2003
Anti-spasticity agents for multiple sclerosisD T Shakespeare, M Boggild, C Young
The Cochrane Database of Systematic Reviews|November 1, 2001
Anti-spasticity agents for multiple sclerosisD T Shakespeare, M Boggild, C Young
The Cochrane Database of Systematic Reviews|October 18, 2000
Anti-spasticity agents for multiple sclerosisD T Shakespeare, C A Young, M Boggild
Neurology|March 1, 1989
Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failureK Ray-Chaudhuri, I F Pye, M Boggild
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2003
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatmentJ Craig, C A Young, M Ennis, et al.
Practical Neurology|March 18, 2008
Myelopathy but normal MRI: where next?S H Wong, M Boggild, T P Enevoldson, et al.
Acta Neurologica Scandinavica|April 21, 2015
The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011S Simpson, S Mina, H Morris, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|October 24, 1992
Intracerebral haemorrhage after dermal nitrate applicationM Boggild
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 1999
The UK Multiple Sclerosis databaseJ Palace, M Boggild
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2009
Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?R Ellis, M Boggild
The Cochrane Database of Systematic Reviews|October 30, 2003
Anti-spasticity agents for multiple sclerosisD T Shakespeare, M Boggild, C Young
The Cochrane Database of Systematic Reviews|November 1, 2001
Anti-spasticity agents for multiple sclerosisD T Shakespeare, M Boggild, C Young
The Cochrane Database of Systematic Reviews|October 18, 2000
Anti-spasticity agents for multiple sclerosisD T Shakespeare, C A Young, M Boggild
Neurology|March 1, 1989
Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failureK Ray-Chaudhuri, I F Pye, M Boggild
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2003
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatmentJ Craig, C A Young, M Ennis, et al.
Practical Neurology|March 18, 2008
Myelopathy but normal MRI: where next?S H Wong, M Boggild, T P Enevoldson, et al.
Acta Neurologica Scandinavica|April 21, 2015
The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011S Simpson, S Mina, H Morris, et al.
Pageof 2